Skip to content

Routine Use of FIBERoptic Bronchoscopic Guidance in Percutaneous TRACHeostomy

The Role of Routine Fiberoptic Bronchoscopic Guidance During Percutaneous Tracheostomy. A Prospective Randomized Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04265625
Acronym
FIBERTRACH
Enrollment
442
Registered
2020-02-11
Start date
2019-12-07
Completion date
2024-12-28
Last updated
2025-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complications

Keywords

Percutaneous tracheostomy, Endoscopic guidance, Fiberoptic endoscopic guidance, Complications

Brief summary

Tracheostomy is one of the most frequently performed techniques in intensive care units. For some authors endoscopic guide as part of the percutaneous tracheostomy (PT) might reduces the incidence of serious complications. However, for others, endoscopic guide increases the procedure cost, increases airway pressure and PaCO2 and sometimes requires the presence of another physician. International guidelines conclude that there is insufficient evidence to support the routine use of bronchoscopy during PT in order to decrease the number of complications. In addition the routine use of endoscopic guide is heterogeneous according the results of six published nation surveys. Extensive randomized trials to compare PT with endoscopic guide and without endoscopic guide are needed in order to clarify this controversial issue. This constitutes the justification of this trial. Hypothesis: Percutaneous tracheotomy performed under endoscopic guide decreases the incidence of perioperative complications of the procedure.

Detailed description

Background Tracheostomy is one of the most frequently performed techniques in intensive care units (ICU). A few years after the description of the percutaneous dilatational tracheostomy (PDT), endoscopic guide as part of the technique was performed in four patients. The authors concluded that the endoscopic guide provided advantages to the realization of PDT. Other authors have state that endoscopy, significantly reduces the incidence of serious complications such as posterior tracheal tears, false passage, pneumothorax and subcutaneous emphysema. However, currently endoscopic guide as part of the percutaneous tracheostomy is controversial. Although for some authors its use reduces the number of complications, others found that endoscopic guide increases the procedure cost, increases airway pressure and PaCO2 and sometimes requires the presence of another physician. Thus, some do not consider it necessary when the physicians have enough experience with percutaneous tracheostomy. International guidelines conclude that there is insufficient evidence to support the routine use of bronchoscopy during percutaneous tracheostomy in order to decrease the number of complications. In addition the routine use of endoscopic guide is heterogeneous according the published surveys. Specifically, in Spain its use was the lowest of the six published nation surveys. Extensive randomized trials to compare percutaneous tracheostomy with endoscopic guide and without endoscopic guide are needed in order to clarify this controversial issue. This constitutes the justification of this trial. Hypothesis Percutaneous tracheostomy performed under endoscopic control does not reduce the incidence of perioperative complications of the procedure in critically ill patients when it is performed by experienced physicians in patients without anatomical abnormalities. Main goal 1. \- To assess the incidence of perioperative complications of percutaneous tracheotomy under endoscopic guide versus blind percutaneous tracheotomy. 2. \- To assess the ventilatory parameters during percutaneous tracheostomy with and without endoscopic control. Methodology Prospective, multicenter randomized study. Patients admitted to the ICU who need tracheostomy due to prolonged mechanical ventilation, who do not have neither contraindications to perform the percutaneous technique nor contraindications to perform fibrobronchoscopy will be randomized. The percutaneous tracheostomy will be carried out with the single-step dilation method. For its realization, the usual protocol will be followed. The included patients will be randomized 1:1 (percutaneous tracheostomy with endoscopic guide vs percutaneous tracheostomy without endoscopic guide). The randomization system will be by closed envelope. A sample size of 221 patients in each branch has been calculated. The percutaneous tracheostomy and fiberoptic bronchoscopy will be performed by staff with experience with both procedures.

Interventions

DEVICEendoscopic guidance

Percutaneous tracheotomy performed by endoscopic guidance

Sponsors

Instituto de Investigación Hospital Universitario La Paz
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Patients over 18 years old requiring tracheotomy due to prolonged mechanical ventilation * That Family members or legal representatives have signed the information sheet and informed consent

Exclusion criteria

* Patients with increased intracranial pressure according to intracranial pressure monitoring or suspected. * Patients who have any absolute or relative contraindication for the percutaneous tracheostomy realization * Patients with difficult airway

Design outcomes

Primary

MeasureTime frameDescription
Number of patients in whom cardiac arrest or death directly related to any complication arising from the technique occurredFrom date of randomization until the ICU dischargeCardiac arrest or death
Number of patients in whom a loss of airway has ocurredFrom randomization until the end of the procedureLoss of airway: Failure to be able to access the airway \> 30 seconds.
Number of patients with atelectasisFrom date of randomization until 24 hours laterAtelectasis: Total or partial lung collapse not present before the technique, evidenced at postoperative control.
Number of patients with hypotensionFrom randomization until the end of the procedureHypotension requiring treatment with vasopressors or \>1000 ml of fluids during the procedure.
Number of patients with barotraumaFrom date of randomization until 24 hours laterBarotrauma: Subcutaneous emphysema, mediastinal emphysema or pneumothorax related to the technique.
Number of patients with posterior tracheal wall injuryFrom date of randomization until 24 hours laterPosterior tracheal wall injury: Injury to membranous trachea by the needle, guide or dilator along with any related consequences (pneumomediastinum, pneumothorax, subcutaneous emphysema, tracheo-esophageal fistula)
Number of patients in whom false passage has ocurredFrom randomization until the end of the procedureFalse passage: Dilatation or insertion of the cannula out of the trachea lumen.
Number of patients with bleedingFrom date of randomization until 24 hours laterBleeding with haemodynamic derangement or needing surgical review or transfusion of packed red cells.
Number of patients with hypoxemiaFrom date of randomization until 24 hours laterHypoxemia: Oxygen arterial saturation (SaO2) \< 85% during more than 90 seconds and/or arrhythmia or cardiac arrest related to hypoxemia.

Secondary

MeasureTime frameDescription
Plateau pressureFrom randomization until the end of the procedureMaximum plateau pressure (cmH2O)
Tidal volumeFrom randomization until the end of the procedureMinimum tidal volume (mL)
Arterial Blood GasFrom randomization until 15 minutes after the procedureArterial blood gase at the beginning and the end of the procedure
Peak airway pressureFrom randomization until the end of the procedureMaximum peak airway pressure (cmH2O)
Oxygen saturation (SaO2)From randomization until the end of the procedureMinimum arterial oxygen saturation (SaO2)

Other

MeasureTime frameDescription
MortalityFrom the date of randomization until the hospital dischargeAll-cause mortality at hospital discharge

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 28, 2026